|EACH ML CONTAINS:|
|Trestolone Acetate (MENT)||BP||100mg|
Warning: Inhibition of sperm production
Spermatozoa are produced in the testes of males in a process called spermatogenesis. In order to render a man infertile, a hormone-based male contraceptive method must stop spermatogenesis by interrupting the release of gonadotropins from the pituitary gland. Even in low concentrations, trestolone is a potent inhibitor of the release of the gonadotropin hormones, luteinizing hormone (LH) and follicle stimulating hormone (FSH)
In order for spermatogenesis to occur in the testes, both FSH and the male hormone testosterone must be present. By inhibiting release of FSH, trestolone creates an endocrine environment in which conditions for spermatogenesis are not ideal. Manufacture of sperm is further impaired by the suppression of LH, which in turn drastically curtails the production of testosterone. Sufficient regular doses of trestolone cause severe oligozoospermia or azoospermia, and therefore infertility, in most male patients
Trestostolone is a powerful suppressor of spermatozoa production and is currently being used as a male contraceptive. However, trestolone-induced sterility has been found to be quickly reversible upon discontinuation. Anecdotal evidence shows a 45-90 day reversal in most people with stimulation of LH and FSH. This includes clomiphene and human chorionic gonadotropin (see cycles and stacks for International Anabolics PCT stack)
Dosage & administration:
- Half life
- differs for each ingredient. between 1 and 5 days.
- Adult dosage
- 50mg-200mg per injection ED or EOD for 4 -10 weeks or as required.
- Average Cycle Length
- 300mg-1000mg per week over 4-10 weeks gives the best results.
- CAS Name
- CAS Name
- 17β-propionate; 2α-Methyl-4,5α-dihydrotestosterone 17β-propionate; 2α-Methyl-DHT propionate; 2α-Methyl-5α-androstan-17β-ol-3-one 17β-propionate